Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis.
Publication year
2012Source
Diabetologia, 55, 5, (2012), pp. 1247-57ISSN
Annotation
01 mei 2012
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Molecular Biology
Tumorimmunology
Nuclear Medicine
Medical Oncology
Paediatrics - OUD tm 2017
Journal title
Diabetologia
Volume
vol. 55
Issue
iss. 5
Page start
p. 1247
Page end
p. 57
Subject
IGMD 1: Functional imaging; NCMLS 2: Immune Regulation; ONCOL 3: Translational research NCMLS 2: Immune RegulationAbstract
For more than a decade, researchers have been trying to develop non-invasive imaging techniques for the in vivo measurement of viable pancreatic beta cells. However, in spite of intense research efforts, only one tracer for positron emission tomography (PET) imaging is currently under clinical evaluation. To many diabetologists it may remain unclear why the imaging world struggles to develop an effective method for non-invasive beta cell imaging (BCI), which could be useful for both research and clinical purposes. Here, we provide a concise overview of the obstacles and challenges encountered on the way to such BCI, in both native and transplanted islets. We discuss the major difficulties posed by the anatomical and cell biological features of pancreatic islets, as well as the chemical and physical limits of the main imaging modalities, with special focus on PET, SPECT and MRI. We conclude by indicating new avenues for future research in the field, based on several remarkable recent results.
This item appears in the following Collection(s)
- Academic publications [205104]
- Faculty of Medical Sciences [81055]
- Faculty of Science [32347]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.